The Rivkin Pilot Grant supports investigators testing innovative, multidisciplinary ideas in ovarian and related gynecologic cancers, generating early evidence to advance research and seek future funding.
Funder: Ovarian Cancer Research Alliance
Due Dates (Anticipated): March 2027 (LOI) | June 2027 (Full proposal)
Funding Amounts: Up to $50,000 annually for two years ($100,000 total)
Summary: Supports innovative pilot research in ovarian and related gynecologic cancers that can generate early evidence for future work.
Key Information: Principal investigators must hold a doctoral degree and submit no more than one LOI as PI per grant cycle.
Ovarian Cancer Research Alliance (OCRA) offers Rivkin Pilot Grants to advance innovative research in ovarian cancer and related gynecologic cancers. Continuing the legacy of the Rivkin Center, the program supports multidisciplinary projects that test feasibility, generate preliminary data, and show clear translational relevance and potential for subsequent external funding.
Projects may also analyze data from previously funded clinical trials when the analysis advances a novel hypothesis or generates proof-of-concept findings. OCRA considers whether the grant will help investigators build or strengthen a team capable of high-impact research.